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Background: Immune system cells are known to affect loss of neurons due to injury or disease. Recruitment of
immune cells following retinal/CNS injury has been shown to affect the health and survival of neurons in several
models. We detected close, physical contact between dendritic cells and retinal ganglion cells following an optic
nerve crush, and sought to understand the underlying mechanisms.
Methods: CD11c-DTR/GFP mice producing a chimeric protein of diphtheria toxin receptor (DTR) and GFP from a
transgenic CD11c promoter were used in conjunction with mice deficient in MyD88 and/or TRIF. Retinal ganglion
cell injury was induced by an optic nerve crush, and the resulting interactions of the GFPhi cells and retinal
ganglion cells were examined.
Results: Recruitment of GFPhi dendritic cells to the retina was significantly compromised in MyD88 and TRIF
knockout mice. GFPhi dendritic cells played a significant role in clearing fluorescent-labeled retinal ganglion cells
post-injury in the CD11c-DTR/GFP mice. In the TRIF and MyD88 deficient mice, the resting level of GFPhi dendritic
cells was lower, and their influx was reduced following the optic nerve crush injury. The reduction in GFPhi dendritic
cell numbers led to their replacement in the uptake of fluorescent-labeled debris by GFPlo microglia/macrophages.
Depletion of GFPhi dendritic cells by treatment with diphtheria toxin also led to their displacement by GFPlo microglia/
macrophages, which then assumed close contact with the injured neurons.
Conclusions: The contribution of recruited cells to the injury response was substantial, and regulated by MyD88 and
TRIF. However, the presence of these adaptor proteins was not required for interaction with neurons, or the
phagocytosis of debris. The data suggested a two-niche model in which resident microglia were maintained at a
constant level post-optic nerve crush, while the injury-stimulated recruitment of dendritic cells and macrophages led to
their transient appearance in numbers equivalent to or greater than the resident microglia.
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Neurodegenerative processes adversely affect vision in a
significant portion of the human population, and are as-
sociated with glaucoma, age-related macular degener-
ation (AMD), diabetic retinopathy, ischemia, retinopathy
of prematurity and traumatic injuries [1-4]. Irrespective
of the cause of the degenerative process, it is evident
that the immune system can be protective or pathogenic
in neurodegeneration [5]. Studies show that microglia* Correspondence: grege001@umn.edu
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unless otherwise stated.(MG) are not simply the scavengers of the nervous sys-
tem; instead, they appear to play complicated, even
contradictory, roles [6,7]. MG have been associated with
clean-up of dead/dying neurons with minimal inflamma-
tion [8,9], restoration of health to damaged peripheral
nervous system (PNS) neurons [10], and promotion of
inflammation through secretion of proinflammatory
molecules [11,12]. They also appear to kill neurons
through effector mechanisms that include production of
reactive oxygen species which disrupt axonal transport
[13], and cytotoxic cytokines including TNF. FasL ex-
pression by MG may contribute to the death of Fas+
neurons [14,15].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Within minutes of a focal injury to brain or retina,
neighboring MG extended processes to the site [16-18].
At later time points post-injury, other cells participate.
The optic nerve crush (ONC) has been used as a model
for neural injury, giving a discreet injury to a limited
number of neurons, retinal ganglion cells, that pro-
gresses on a well-studied, consistent course [19,20]. By
two to three days post-ONC, we found evidence that
dendritic cells (DC) were recruited to the retina, increas-
ingly associated with the ganglion cell layer (RGC) and
the nerve fiber layer (NFL) of the retina, and increased
in number for approximately ten days, equaling the MG
in total number per retina [21]. The number of DC
remained elevated for more than two months, gradually
declining in number. Many DC were closely associated
with the axons of RGC post-ONC [21]. DC dominated
this close interaction for at least three weeks post-injury,
raising the question of whether their response was pro-
tective, harmful, or unrelated to survival of RGC.
The well-known function of DC as antigen presenting
cells may be important, consistent with reports that sug-
gest that adaptive immunity mediated by T cells may be
neuroprotective [22-25]. However, very few lymphocytes
were found after this sterile injury, suggesting that the
activity of these DC may not be limited to antigen pres-
entation. We present evidence that DC are active partici-
pants in the injury response. Analysis of DC from
MyD88 and TRIF single and double knockout mice
showed that DC in the knockout mice were much less
efficiently recruited to the retina post-injury, but the
smaller number that was present remained fully able to
take up DiI+ debris via phagocytosis of DiI-labeled RGC
and axon debris after an ONC. MG compensated for the
reduced number of DC in MyD88 and/or TRIF deficient
mice by increasing their uptake of DiI+ debris.
Materials and methods
Animals
CD11c-DTR/GFP mice (CDG) mice on the B6 back-
ground (B6.FVB-Tg(Itgax-DTR/EGFP)57Lan/J), express
a chimeric protein comprised of GFP and the diphtheria
toxin receptor (DTR) under control of the CD11c pro-
moter [26]. Wild type (wt) C57BL/6J (B6) mice were ob-
tained from Jackson Laboratory (Bar Harbor, ME, USA).
MyD88/TRIF double knockout mice (MTdko) on the
B6 background were bred from pairs obtained from
Dr. Stephen Jameson, University of Minnesota. The
double knockout mice were backcrossed to B6 mice to
generate the single knockout mice, MyD88-deficient
(Mko) mice and TRIF-deficient (Tko) mice. The single
and double knockout mice were backcrossed to CDG
mice to allow visualization of the GFP reporter for CD11c.
All mice were CD45.2. Transgenic mice were bred inhouse. All mice were rd8 negative. Mice were handled in
accordance with the Association for Research in Vision
and Ophthalmology Statement for the Use of Animals in
Ophthalmic and Vision Research and University of
Minnesota Institutional Animal Care and Use Committee
guidelines.
Optic nerve crush
The optic nerve crush (ONC) was performed as de-
scribed [21,27], except for use of #2197E DSAEK forceps
(Ambler Surgical Corp., Exton, PA, USA) for the crush
procedure. Briefly, the optic nerve was clamped for three
seconds at a point 1 to 2 mm from the posterior pole of
the globe.
RGC labeling
Injection of fluorescent dye, either Fluorogold (FG) or
di-alkyl-indocarbocyanine (DiI), into the superior col-
liculus was done to retrogradely label the RGC. Manipu-
lations were done in a stereotactic device. A midline
incision was made in the scalp to expose the skull. A
unilateral 1 mm hole was drilled at –3.5 mm from
bregma and +1.2 mm from midline. A 10-μl syringe and
non-coring needle attached to a micromanipulator was
inserted to a depth of −2.5 mm from the surface of the
brain. Four percent dye in 1.5 μl of saline was injected
over the course of 2 minutes. After slow removal of the
syringe, the scalp was sutured with 4-0 silk. FG was used
to count surviving RGC and was administered after the
ONC four days before retina harvest. The FG diffuses
rapidly to the opposite hemisphere of the brain, so that
the RGC of both retinas become equivalently stained
even if the dye was injected unilaterally in the brain. DiI
was used to label the RGC with red fluorescence for ex-
periments to detect labeled RGC debris in the mono-
nuclear cells of the retina by flow cytometry and
fluorescence microscopy. DiI was administered seven to
ten days before the ONC.
Flow cytometry of retinal cells
Mice were euthanized, perfused, and the retinas re-
moved as described [21]. Retinas were dissociated in
0.5 μg/ml Liberase/Blendzyme3 (Roche, Indianapolis, IN,
USA) and 0.01% DNase in Dulbecco’s phosphate-
buffered saline (DPBS), stained with indicated anti-
bodies, and analyzed as described [21,28,29]. Analyses
were based on the examination of all immune cells col-
lected from one or more retinas, as specified.
Immunostaining of retinal flatmounts
Retinal flatmounts were prepared, stained, and analyzed
as described [21]. Primary antibodies included: rat anti-
CD11b to stain myeloid cells (clone M1/70, BD Biosci-
ences, San Jose, CA, USA) and anti-β3-tubulin to stain
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bodies (Invitrogen, Life Technologies, Grand Island, NY,
USA) included: Alexa Fluor 594 donkey anti-rat IgG for
anti-CD11b; and Alexa Fluor 405 rabbit anti-mouse IgG
for anti-β3 tubulin. Cell nuclei were stained with 4′,6-
diamidino-2-phenylindole (DAPI, Vector Laboratories,
Burlingame, CA, USA).TUNEL-stained retinal sections
Eyes were enucleated and immediately snap-frozen in
Tragacanth (Sigma, St. Louis, MO, USA). Retinas were
sectioned (12 μm) through the optic nerve. Detection of
apoptotic nuclei was accomplished by terminal deoxynu-
cleotidyl transferase-mediated dUTP nick-end labeling
(TUNEL) using the In Situ Cell Death Detection Kit,
Fluorescein (Roche, Indianapolis, IN, USA). Slides were
cover slipped with VECTASHIELD Mounting Medium
containing DAPI (Vector Laboratories, Burlingame, CA,
USA) to visualize the nuclei.Retinal morphology measurements
The density of nuclei in the ganglion cell layer (GCL)
was measured on DAPI-stained retinal sections. For each
retinal section, three images were taken on either side of
the optic nerve at 500 μm intervals. The length of the
GCL was measured using BIOQUANT NOVA PRIME
6.90.10 (BIOQUANT Image Analysis, Nashville, TN,
USA). The number of DAPI-stained nuclei in the GCL
was counted from these images and normalized to the
length of the retinal section to calculate the nuclei dens-
ity (nuclei/μm). The same retinal sections were also
stained with TUNEL. The TUNEL+ nuclei in these same
sections were counted and cross-referenced with the
DAPI stained nuclei to ensure presence of a nucleus.Figure 1 CDG and B6 retinal ganglion cells (RGC) survive similarly aft
DSAEK forceps for the ONC. *All post-ONC counts of RGC differed from no
RGC counts represent the RGC counts of both retinas after unilateral injection
opposite, unmanipulated side. Counts are average RGC numbers/retinal field
N = number of mice. For example, an N of 4 represents 32 fields. Field size = 0Statistics
Data, whether expressed numerically or graphically as a
mean, included the standard deviation; standard error
was not used. Data analyses for significance were done
with the InStat3 package from GraphPad Software (San
Diego, CA, USA). Comparisons of three or more data
sets were done with one way analysis of variance
(ANOVA) using the Dunnett multiple comparisons test
with a designated control set. Comparisons of two data
sets were done with a two-tailed, unpaired t-test.
Results
Optic nerve crush injury
The ONC procedure yielded a significant, reproducible
sterile injury to the RGC (Figure 1), providing the op-
portunity to study factors that may affect recruitment of
mononuclear cells and their interactions with the injured
RGC. Survival of RGC from wt B6 mice and CDG mice
was similar (Figure 1). The autocount procedure and re-
sults are described in the Additional file 1: Figure S1. Ex-
trapolating our counts/field to the entire normal C57BL/
6J retina yielded a total of 46,324 ± 1,968 RGC, which
compares well with values from other reports obtained
by counting axons (44,860 [30] and 47,113 [31]) or
retrograde labeled RGC (49,823 [32]).
Identification of retinal DC and MG/macrophages
We previously showed that the CD11b+GFPhi cells in
quiescent CDG retina were morphologically similar to
MG [21]. Flow cytometry showed that the CD11b+GFPlo
and CD11b+GFPhi DC in the CD45med region commonly
associated with MG were indistinguishable by several
parameters, including expression of F4/80, whether from
quiescent or post-ONC retinas (Figure 2A). The CD45hi
region also contains a small number of CD11b+ cells,er an optic nerve crush (ONC). RGC survive in greater numbers using
rmal controls, as well as the contralateral RGC, P < 0.05. Normal control
into the superior colliculus. Ipsilateral - manipulated side; contralateral -
where each retina count is the average of eight fields/retina, ± SD.
.190 mm2.
Figure 2 (See legend on next page.)
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Figure 2 Retinal GFPhi cells are CD11b+ and express F4/80. The GFPhi cells in the retina of CDG mice are found in the CD45med region
associated with microglia (MG), and in the CD45hi populations. (A), Analysis of F4/80 and GFP expression in retinal CD45med cells from naive B6,
naive CDG, and CDG mice post-ONC. (B), Expression of GFP and F4/80 in CD45hi cells from the same retinas shown in (A). The quadrants are
labeled with the percent of cells contained in each quadrant.
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post-ONC was easily detected by sequentially gating on
CD45+ cells, and then confirming that the GFPhi cells
expressed CD11b. At 7 days post-crush, the GFPhi cells
accounted for approximately 40% of the total CD45+11b+
cells. The CD11b+GFPhi cells do not express detectable
levels of Ly6G (clone 1A8) or Ly6C/G (Gr-1, clone RB6-
8C5 (data not shown)), showing that neutrophils did not
contribute to the counts. These properties allowed identi-
fying these cells in four groups (Table 1) for the studies
that follow.
Retinal DC associate with RGC axons and soma after
an ONC
In quiescent retina, a small number of ramified GFPhi
DC were distributed in the inner plexiform layer (IPL)
immediately below the soma of the RGC (Figure 3A).
This morphology was unchanged at day 1 post-ONC
(Figure 3A). DC in close association with injured RGC
were first detected three days post-ONC, when a careful
search of three retinas found a few GFPhi DC closely as-
sociated with RGC nerve fibers (Figure 3A). Dendrites
(small blue arrows) show GFPhi DC in the IPL at day 1
and day 3a. Large blue arrows show axons bundled into
nerve fibers (day 3b). Somata (white/blue arrows) are
shown in days 3b and 7a. By five days post-ONC, nu-
merous close associations between the GFPhi DC and
nerve fibers were found (Figure 3A). Counts of represen-
tative 20X fields from three retinas harvested at day 5
post-ONC showed that 16% of the total GFPhi DC in
retina were closely associated with nerve fibers or soma.
Close association of the GFPhi DC with the NFL peaked
at 7 to 11 days (Figure 3A). We previously showed that
GFPhi DC dominated the interaction of CD11b+ cell
populations with the NFL at seven days post-ONC [21].
By 11 days post-ONC, the density of β3-tubulin+ fibersTable 1 Phenotype of the GFPhi DC and GFPlo mononuclear
cells from retina
CDG retinal cells GFPa CD45a CD11ba F4/80a
GFPhi DC (CD45med) hi med hi +
GFPhi DC (CD45hi) hi hi hi +
MG/monocyte/macrophage
(CD45med)
lob med hi +
monocyte/macrophage (CD45hi) lo hi hi +
aFlow cytometry.
bResistant to DTx depletion in CDG mice.in the NFL was reduced, but GFPhi DC were still found
in close contact with remaining fibers (Figure 3A). At
five or more days post-ONC, DC were found in contact
with the RGC soma, and these appeared to be engulfing
the RGC (Figure 3B). The close association of the DC
with the RGC and their axons raised questions about
the molecular basis for these interactions that may affect
RGC survival following an ONC.Roles of DC versus MG/macrophages in clearance of
damaged RGC
Candidate phagocytic cells in the retina that may clear
damaged RGC are CD45+CD11b+Ly6G− mononuclear
cells. To detect the relative contributions of MG, re-
cruited macrophages, and recruited GFPhi DC to the
clearance of injured RGC post-ONC, the RGC were pre-
labeled with DiI to detect CD45+CD11b+ cells that had
phagocytosed DiI-labeled RGC. The CD11b+ phagocytic
cells in the retina are found in two populations based on
CD45 staining intensity, CD45hi and CD45med (Figure 4A,
Table 1). The CD45hi population of CDG retina contains
CD11b+ cells that include GFPhi DC, GFPlo monocytes,
macrophages, and polymorphonuclear granulocytes (PMN).
The PMN were excluded by staining with clone 1A8,
which identifies Ly6G+ PMN. Although PMN are re-
cruited onto the retinal surface at early time points post-
ONC, a PMN in contact with the NFL or RGC was not
observed (data not shown), and they were routinely ex-
cluded from further analysis. The CD45med population
post-ONC includes MG, recruited macrophages and
GFPhi DC (Figure 4A, Table 1).
As shown by others, and in Figure 4B, RGC were well-
labeled seven days after injection of DiI into the superior
colliculus [33]. After seven days DiI labeling, mice were
given an ONC. Seven days post-ONC, DiI+ RGC were
being engulfed by GFPhi DC, as shown in a series of 1-μm
optical sections from confocal microscopy (Figure 4B).
Slices 2, 4, 6 and 8 show the association of the DC with
individual RGC somata at 2-μm increments. Further veri-
fication that CD11b+ cells would take up DiI-labeled cellu-
lar debris after an ONC was found by flow cytometric
analysis of retinas after seven days DiI labeling followed
by an ONC. The retinas were harvested at day 6 post-
ONC. DiI labeling was found in both the GFPhi DC and
GFPlo MG/macrophages from the CD45med population
(Figure 4C). This gating strategy was used for further ana-
lysis of DiI+ DC and macrophages.
Figure 3 Recruitment, redistribution and interaction of retinal GFPhi DC with retinal ganglion cells (RGC) and their axons following an
optic nerve crush (ONC) injury. (A), GFPhi DC in naive retina, and at 1, 3, 5, 7, and 11 days post-ONC. GFPhi DC, green; isolectin B4-stained blood
vessels, red; anti-β3 tubulin stained RGC somata (blue/white arrows), nerve fibers (large blue arrows), and dendrites (small blue arrows). (B), GFPhi
DC surround and engulf RGC somata ten days post-ONC. DAPI, blue; GFPhi DC, green.
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Figure 4 Detection of retinal ganglion cell (RGC) phagocytosis by GFPhi and GFPlo CD11b+ cells in CDG retina post-ONC. (A) Depiction
of CD45hi and CD45med gating, elimination of 1A8+ PMN, and selection for CD11b+ cells that are GFPlo or GFPhi. (B) Sequential confocal sections
of GFPhi DC engulfing DiI-labeled RGC seven days post-ONC. DiI-labeled RGC, red; GFPhi DC, green; DAPI-stained nuclei, blue. (C) Detection and
quantitation of DiI-labeled CD45medCD11b+GFPhi DC and GFPlo cells by flow cytometry. Ipsilateral retinas were labeled by injection of DiI into the
superior colliculus. After seven days, mice were given an ONC; retinas were harvested six days later.
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determined next. Based on the progression of RGC
apoptosis, estimated by counts of TUNEL+ cells in theFigure 5 Phagocytosis of retinal ganglion cells (RGC) following an op
an ONC. (B) Analysis of DiI uptake in GFPhi DC and GFPlo MG/macrophages
superior colliculus. After 7 days the mice were given an ONC; retinas were
flow cytometry as shown in Figure 4. All cells in (B) are CD11b+.RGC layer (Figure 5A), DiI-labeled retinas were har-
vested from 7 to 17 days post-ONC and analyzed by flow
cytometry to detect DiI uptake by phagocytic CD11b+tic nerve injury (ONC). (A) Time course of RGC apoptosis following
following an ONC. Retinas were labeled by injection of DiI into the
harvested 7, 10, 13, and 17 days later. CD45+ cells were examined by
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number of DiI+CD11b+ cells peaked at ten days post-
ONC in both CD45hi and CD45med populations. Although
the total number of CD11b+ cells in the CD45hi popula-
tion was much lower than the CD45med population, the
frequency of CD45hiDiI+ cells at day 10 post-ONC was
much higher (14%, 27 of 191 cells), than that found in the
CD45med population (2.5%, 115 of 4,638 cells) (Figure 5B).
Of the total CD45hiDiI+CD11b+ cells, 89% were GFPhi,
whereas only 35% of the CD45medDiI+ cells were GFPhi.
These results showed that mononuclear cells were actively
phagocytosing DiI-labeled RGC, and proportionately more
of the DiI+ cells were CD45hi DC. Since day 10 post-ONC
was the peak of DiI uptake, day 10 was used for subse-
quent experiments.
MyD88/TRIF and recruitment of CD11b+ myeloid cells to
retina post-ONC
Given the active participation of mononuclear cells in
the clearing of RGC debris, we sought evidence for the
contribution of toll-like receptors (TLR) to this response.
A number of recent reports suggested roles for TLR in
the responses of CNS tissue to injury and/or neurode-
generation [34,35]. The adaptor proteins MyD88 and
TRIF link TLR ligation to NFκB activation. Their dele-
tion has been reported to reduce neural inflammatory
responses to infectious agents [36-39], and has beenFigure 6 Recruitment of CD45medGFPhi cells to retina in Tko, Mko, or
days after an ONC. Numbers in the quadrants are percents, and are the ave
populations are shown.associated with an increase in neural deficits or dimin-
ished neurotoxicity [40]. Since the GFP+ DC appeared in
substantial numbers in the retina following injury, were
closely associated with injured neurons, and phagocy-
tosed RGC and axon debris, we asked if these activities
correlated with TLR-mediated sensing of the local envir-
onment. Mko, Tko, and MTdko mice were backcrossed
to the CDG background to examine the effects of elim-
inating these proteins on the influx of GFPhi DC and
GFPlo MG and macrophages in response to the ONC.
Prior to injury, Tko and MTdko mice had reduced num-
bers of CD45medGFPhi DC in the retina compared to
control mice (Figure 6, Top). Deficiencies in either
MyD88 or TRIF or both also led to a substantial reduc-
tion in the number of GFPhi DC that were recruited in
response to an ONC (Figure 6, Bottom). The double
knockout mice gave the greatest decline in retinal GFPhi
DC for both basal and post-ONC conditions, suggesting
that the NFκB pathway regulated the response of mono-
nuclear cells to an ONC. The flow cytometry conditions
shown in Figures 4 and 6 were then analyzed for DiI to
generate the data for Figures 7 and 8, which follow.
MyD88/TRIF deficiency diminished uptake of DiI-labeled
RGC debris by GFPhi DC post-ONC
The CD45hi and CD45med populations were examined
for the effects of MyD88 and/or TRIF deficiency onMTdko mice on the CDG background. Retinas were harvested ten
rages of at least four samples. P-values for differences in the
Figure 7 DiI uptake by CD45hi cells. (A) Flow cytometric analysis of DiI uptake by GFPhi and GFPlo cells in the CD45hi population of retina from the
indicated strains harvested after retrograde labeling of RGC with DiI. The retina was DiI labeled by injection of DiI into the superior colliculus seven days
prior to the ONC. Retina was harvested ten days post-ONC where indicated. (B) Summary of cell counts and P-values in mice receiving DiI and an ONC.
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cells in the CD45hi population became labeled with DiI
after an ONC, regardless of the presence or absence of
MyD88 or TRIF (Figure 7); the differences due to
MyD88 and TRIF activity were found in the number ofFigure 8 DiI uptake by CD45med cells. (A) Flow cytometric analysis of the
retina from the indicated strains harvested after retrograde labeling of RGC wi
the ONC. Retina was harvested ten days post-ONC. Application of the DiI label
of cell counts and P-values.cells that were recruited by the injury. In control CDG
mice, 39% of the GFPhi DC were DiI labeled (yellow versus
green bars), compared to 6% of CD11b+GFPlo cells that
were found to be DiI+ (red versus gray bars) (Figure 7B).
Although the recruitment of GFPhi DC into the CD45hiuptake of DiI by GFPhi and GFPlo cells in the CD45med population of
th DiI via injection of DiI into the superior colliculus seven days prior to
, and performance of the ONC were as indicated on the axis. (B) Summary
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DiI+GFPhi cells relative to GFP+ cells did not change sig-
nificantly (Figure 7B). The fraction of DiI+GFPlo cells
ranged from 6 to 10%, and was not significantly different.
Although the total of CD45hiGFPhi cells declined substan-
tially (from 82 to 23), the total number of DiI+ cells was
not different (Figure 7B); the GFPlo cells appeared to com-
pensate for the smaller number of GFPhi DC in the uptake
of DiI-labeled debris. Clearly, the DiI+GFPhi DC and the
DiI+GFPlo cells responded differently to the deficiencies in
MyD88 and/or TRIF.
As shown above, CD11b+DiI+ cells were also found in
the CD45med population, but their frequency was much
lower than seen in the CD45hi populations (Figure 8A).
The effect of MyD88/TRIF deficiency differed, relative to
the results seen above for CD45hi cells. For example, the
number of DiI+ cells, relative to the total number of
CD11b+ cells, was constant in control versus MTdko
mice (1:46 in CDG retina versus 1:47 in CDG x MTdko
retina) (Figure 8B). Although the total number of cells in
the CD45med population of CDG retina was approxi-
mately 27-fold higher than in the CD45hi population, the
total number of CD45medDiI+ cells was only 4-fold
higher. A similar comparison of these populations in
MTdko retina showed an 11-fold difference in total cell
number and a 2.5-fold difference in DiI+ cells.
The basis for maintaining the DiI uptake in the face of
a substantial decrease in GFPhi DC is the significant shift
in the distribution of DiI+ cells. Their frequency in GFPhi
cells from CDG x MTdko retina was higher than in
GFPhi cells from CDG retina (0.015 in CDG retina versus
0.068 in CDG x MTdko retina; P < 0.05). Conversely, the
proportion of DiI+GFPlo cells was not different in the
CDG versus CDG x MTdko retina (0.020 versus 0.033,
NS) (Figure 8B). Since the number of GFPhi DC/retina
substantially declined in the MTdko mice (P < 0.001), but
the DiI+ cells did not, showed that uptake of debris was
not significantly compromised by MyD88 and/or TRIF de-
ficiency. The effect of MyD88/TRIF deficiency was more
closely associated with recruitment of GFPhi cells. The
GFPhi DC clear debris with similar efficiency, even though
their numbers declined.
Depletion of GFPhi cells from retina by systemic DTx
reveals their replacement with GFPlo cells
The results above revealed an altered response to injured
RGC following an ONC in MyD88 and/or TRIF defi-
cient mice. The GFPhi DC population was most actively
associated with injured RGC, and most affected by ma-
nipulations of MyD88 and TRIF. Since they are DTx
sensitive, DTx treatment of the mice allowed studies of
the participation of DC in RGC degeneration post-ONC,
within the context of MyD88 and TRIF deficiencies. Sev-
eral DTx treatment protocols were examined to confirmthe DTx sensitivity of retinal DC, and devise DTx treat-
ment protocols that would allow comparison of the
ONC injury response in the presence or absence of ret-
inal DC.
To explore differences between GFPhi DC versus GFPlo
macrophages with respect to the close association with
RGC axons in the NFL post-ONC, systemic injections of
DTx were examined. The ip (intraperitoneal) route was
chosen to facilitate in vivo imaging, since the optical prop-
erties of the cornea would be preserved, and to establish
that DTx readily crossed the blood/retinal barrier. Serial
fundus photographs showed that DTx treatment via ip in-
jection effectively depleted GFPhi DC recruited to the ret-
ina by an ONC (Figure 9A-C). Panel A showed an
elevated number of GFPhi DC at 12 days post-ONC. Panel
B showed noticeable depletion in the same retina one day
after ip injection of 200 ng DTx. Panel C revealed that two
days post-DTx injection gave near-total depletion of GFPhi
cells. Six serial ip injections of 10 ng DTx, or two ip injec-
tions of 100 ng, substantially depleted the GFPhi DC from
uninjured versus crush-injured retinas, respectively, based
on flow cytometry (Figure 9D). Importantly, both showed
retention of GFPloCD11b+ cells representing the MG/mac-
rophages. Direct counts of GFPhi cells in retinal flatmounts
confirmed their depletion (Figure 9E). However, repeated
systemic use of DTx for more than one week, even at low
doses, was toxic. Accordingly, the short-term, high-dose
protocol was used to explore the observation above that
the MG replaced the DC interaction with RGC and axons,
physically and functionally, in the MTdko mice.
Analysis of DTx depletion of GFPhi DC by confocal
microscopy of retinal wholemounts of ONC-injured
CDG retinas given saline or 200 ng DTx ip showed de-
pletion of the GFPhi DC from the nerve fibers of the
RGC (Figure 9F-K). In the saline-treated control mouse,
multiple GFPhi DC in close contact with the nerve fibers
were found, and only a single GFPlo cell can be seen
(Figure 9I). GFPhi DC were prominent in the underlying
IPL (Figure 9J and K). We previously showed that at
18 hours post-DTx, the retinal GFPhi DC were depleted
and the axons showed no association with GFPhi cells or
with GFPloCD11b+ MG/macrophages. Instead, the MG/
macrophages were seen intact, in the same field, below
the RGC/NFL [21]. We show here that extending the
time after DTx treatment to 48 hours before harvest re-
vealed replacement of the GFPhi DC by the GFPlo mac-
rophages/MG on the nerve fibers (Figure 9F), and
continued presence of GFPlo MG/macrophages in the
underlying IPL (Figure 9G and H).
A two-niche model
Taken together, the data supports a two-niche model for
resident and recruited cells in retina (Figure 10). Niche 1
(N1) is occupied by MG/macrophages. In the resting
Figure 9 Systemic administration of DTx to the CD11c-DTR/GFP mice leads to depletion of the GFPhi DC. (A-C) Serial fundus photographs
of the same retina following an ONC and DTx treatment via ip injection. (A) GFPhi DC at 12 days post-ONC. (B) Fundus photograph of retina one
day after ip injection of 200 ng DTx. (C) Photograph of retina two days post-ip DTx injection. (D) Flow cytometry of retina following ip injection
of DTx under two different protocols; six daily injections of 10 ng into a naive mouse, and 2 injections of 100 ng into a mouse at days 11 and 12
post-ONC. (E) Daily serial injections of 10 ng DTx in naive mice. (F-K) Confocal microscopy of retinal flatmounts in ONC-injured retinas. (F-H) DTx
(200 ng) was injected ip 48 hours prior to harvest, at 15 days post-ONC. (F) Cells and nerve fibers in the NFL post-DTx. (G-H) Cells at two levels in
the IPL. All images in each vertical column are from the same confocal field at different depths into the retina. (I-K) Saline, 1 μl, was injected ip
48 hours prior to harvest, at 15 days post-ONC. (I) Cells and nerve fibers in the NFL. (J-K) Cells at two levels in the IPL. GFPloCD11b+ cells stained
red; GFPhiCD11b+ cells stained yellow-green. NFL, nerve fiber layer; IPL, inner plexiform layer at two depths is shown, immediately below the
retinal ganglion cell layer (RGC) soma, and adjacent to the INL.
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niche 2 (N2). Upon stimulation, the majority of cells oc-
cupy an expanding N2 population. Shrinkage of N2 oc-
curs with resolution, although levels remain somewhat
elevated over time. Evidence from the MTdko mice
suggests a role for NFκB signaling in the migration of cells
into the retina under both resting and stimulated
conditions.
Discussion
We previously reported that DC identified as CD11b+
GFPhi cells in CDG mice strongly responded to retinal
injury, and that their numbers often equaled those of the
MG, or other recruited GFPlo macrophages [21]. DC are
central components in innate and adaptive immunity,
expressing a wide range of receptors that sample the en-
vironment for molecules indicative of cell health, infec-
tion or disease. Their extensive and close association
with RGC and their axons after an ONC raised the pos-
sibility that they were active participants in the RGC in-
jury response. TLR, and several other receptors, areimportant sensors linked to NFκB via the adaptor pro-
teins MyD88 and TRIF [41]. Some studies have shown
that neural inflammation was reduced, and neuron sur-
vival enhanced following injuries in MyD88- or TRIF-
deficient mice [42-45], while others reported that
MyD88 deficiency led to exacerbation of the injury re-
sponse and less neuroprotection [46]. We explored the
retinal DC response in mice deficient in one or both
adaptor proteins.
Unlike MG, DC were transient participants in the injury
response, first observed interacting with the NFL at three
days post-injury, rising rapidly to peak at seven to thirteen
days post-injury, and then declining in number. The sub-
population of retinal GFPhi DC that expressed CD45 at a
high level, resembling that of circulating myeloid DC pro-
genitors, was most active in acquiring the DiI label con-
tained in the RGC. GFPhi cells engulfing DiI-labeled RGC
soma post-ONC were readily identified by fluorescence
microscopy. GFPhi DC with CD45 expression at a lower
level similar to MG also took up DiI post-injury, as did
MG/macrophages that were CD45med and GFPlo.
Figure 10 A two-niche model for resident and recruited cells in retina post-injury. The sizes of the niches, N1 (MG/macrophage niche) and
N2 (GFPhi DC niche), as well as the arrows denoting pathways, were drawn to suggest relative sizes, and changes due to injury. VEC, vascular
endothelial cells.
Heuss et al. Journal of Neuroinflammation 2014, 11:143 Page 13 of 16
http://www.jneuroinflammation.com/content/11/1/143A key difference between GFPhi DC and MG is that
relatively few GFPhi DC remain in the retina long-term,
whereas MG are defined as long-term resident macro-
phages. Emigration of GFPhi DC from retina during in-
jury resolution appears unlikely to occur by lymphatic
drainage, but their numbers decline by an unknown
mechanism. Their decline in numbers suggests that the
numbers of DiI+GFPhi DC may be underestimated due
to turnover. A few thousand GFPhi DC appear, have the
opportunity to acquire DiI+ debris, and disappear with
their label over the course of two to three weeks, while
the number of MG remains relatively constant.
T cell adaptive immune responses may contribute to
neuroprotection. A number of neurodegenerative dis-
eases/injuries are ‘sterile’, so that the antigens are limited
to self-antigens. Nervous system self-antigen targets for
immunopathogenic CNS autoimmune responses were
reported to promote RGC survival post-ONC [47],perhaps by activated autoreactive T cells secreting neuro-
trophic factors promoting neuron survival [48]. Self-
reactive Tregs were found to reduce RGC survival [23,24].
DC are the prototypical antigen presenting cells, and we
showed elsewhere that retinal GFP+ DC present antigen
to antigen-specific T cells [29], and that retinal DC upreg-
ulate MHC class II expression following ONC [21]. These
properties may further link the role of retinal DC to T
cells and influence neuroprotection.
Although infiltrating monocytic cells were the major
source of TLR+ cells in traumatic brain injury [34], sig-
naling pathways to NFκB activation in retina are not
straightforward, a result that has been observed by
others [49,50]. In preliminary studies, we found that the
canonical signaling pathway via RelA is not well-used
in vivo by mononuclear cells in murine retina (data not
shown). Further, since the entire mouse shares in adaptor
protein deficiency in these knockout mice, some outcomes
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showing neuroprotection [46] or a lack of effect [51,52] in
MyD88 and/or TRIF-deficient mice.
A two-niche model for resident microglia and transient
dendritic cells
Several observations suggest the presence of two over-
lapping niches in retina, the resident MG niche (N1)
maintained at a relatively stable number, and a transient
niche (N2) created by injury or inflammation that be-
comes occupied by recruited mononuclear cells, includ-
ing GFPhi DC (Figure 10). The finding that sublethal
irradiation protects from glaucoma in DBA/2 J mice by
reducing monocyte entry in the irradiated retina/ON
[53] is consistent with a two-niche model. Retinal DC
appear to occupy N2, distinct from MG/macrophages in
N1. Relative to the GFPhi DC in CDG retina, their re-
cruitment in MTdko retina is substantially reduced (note
Figure 6), but the GFPhi cells that were recruited exhib-
ited a similar ability to take up DiI-labeled RGC follow-
ing an ONC. While the number of GFPhi cells peaked at
seven to thirteen days post-ONC followed by a rapid de-
cline, moderately increased numbers persisted for at
least two months post-ONC [21]. No definitive marker
has been found to distinguish MG from DC, nor have
factors that sustain N1 or N2 been identified. If these
cells occupied the same niche, one would expect that
both MG and the GFP+ cells would decline in propor-
tion to their numbers, as the total number of cells
returned to pre-injury levels. However, in the absence of
catastrophic injury, N1 appears to continue to be occu-
pied by MG, as allelic or other markers of recruited cells
decline [54].
The chemokines and receptors that support recruit-
ment of circulating precursors into multiple tissues, C-C
chemokine receptor-2/C-C chemokine ligand-2 (CCR2/
CCL2) and C-X3-C chemokine ligand-1; CX3CR1, C-
X3-C chemokine receptor-1 (CX3CL1/CX3CR1) [55], do
not appear to be strong candidates for mediating the re-
cruitment, function or maintenance of the cells in retinal
N1 [56], but may have more effect on N2. The effect of
CX3CR1-deficiency on experimental autoimmune uveor-
etinitis (EAU) pathogenesis in mice was found to be in-
significant by one lab [57], but was associated with more
severe EAU by another [58]. Further, no evidence for
effects on retinal development or injury repair was
associated with CX3CR1 deficiency [59]. Evidence for
differences in migration or tracking was found in mice
deficient in both CCL2 and CX3CR1, but degenerative
changes in the retina were not found [60]. Experimental
autoimmune encephalomyelitis (EAE) was found to be
more severe in CX3CR1-deficient mice [61], but in
models for ischemia-reperfusion injury in kidney [62],
spinal cord injury [63], and atherosclerosis [64], diseasewas less severe in CCR2−/− or CX3CR1−/− mice, and at-
tributed to reduced myeloid cell recruitment. Knockout of
either or both of these receptor/ligand pairs yields mice
whose retinal myeloid cells bear some resemblance to the
MTdko mice; that is the MG niche is largely intact, but re-
cruitment is diminished. This is likely due to the role of
NFkB in production of CX3CL1 on endothelial cells [65]
stimulated by IL-1 and TNF [66]. Similarly, upregulation
of CCR2 mediated by TLR2 and TLR4 ligation [67] would
be diminished in MTdko mice, leading to reduced expres-
sion of accessory molecules and integrins associated with
migration of cells into the retina [68-70]. Recent experi-
ments with depletion protocols that may allow specific de-
pletion of CNS MG may yield valuable information on the
N1 niche [71], and strategies to manipulate N2.Conclusions
Use of MyD88 and/or TRIF deficient mice on the CDG
background provided insights into the retinal injury re-
sponse. Mice with single or double deficiencies in these
adaptor proteins had reduced responses, based on find-
ing fewer GFPhi DC in injured retinas post-ONC. Al-
though fewer in number, GFPhi DC retained their ability
to acquire DiI+ debris, suggesting that expression of
these adaptor proteins, and their role in NFκB signaling,
was not a factor in their ability to phagocytose dying
RGC. Recruitment of GFPhi DC, and their phagocytic
activity, were distinct processes in which recruitment
was diminished, but phagocytic activity was not. Instead,
GFPlo MG were more likely to become DiI+, suggesting
that they filled the void left by the reduction in GFPhi
DC in MyD88/TRIF-deficient mice.Additional file
Additional file 1: Figure S1. Comparison of RGC counts/field obtained
by manual and autocounting protocols. FG labeling combined with
automated RGC counting was done to reduce observer bias. Field
size = 0.190 mm2.Abbreviations
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